VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH 2.32 % — DIN 02465043
DICLOFENAC DIETHYLAMINE : 2.32 % · HALEON CANADA ULC · GEL · wholesale supply in Canada
Health Canada status: MARKETED
What is VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH?
VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH 2.32 % contains DICLOFENAC DIETHYLAMINE : 2.32 %. It is listed in the Health Canada Drug Product Database under DIN 02465043, held by HALEON CANADA ULC, supplied as GEL for TOPICAL administration. Health Canada currently lists it as marketed, status dated 25-Jun-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH used for?
VOLTAREN EMULGEL Extra Strength and VOLTAREN EMULGEL Joint Pain Extra Strength (diclofenac diethylamine gel 2.32 % w/w) are indicated for relief of pain associated with recent (acute), localized muscle or joint injuries such as sprains, strains or sports injuries (e.g. sprain of ankle, strain of shoulder or back muscles). This is typically as an adjunct to other measures, such as rest, for the relief of discomfort associated with such injuries.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Diclofenac cost around the world?
Diclofenac is listed on 10 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Belgium publishes a public; Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Morocco | PPV (public price) | 26 | 74 | MAD███.██ |
| United States | acquisition | 6 | 41 | USD███.██ |
| Italy | prezzo al pubblico (classe A) | 28 | 40 | EUR███.██ |
| South Africa | single exit price | 25 | 35 | ZAR███.██ |
| Australia | ex-manufacturer | 9 | 22 | AUD███.██ |
| Romania | max producer price | 15 | 21 | RON███.██ |
| Greece | producer price (ex-factory) | 13 | 13 | EUR███.██ |
| United Kingdom | hospital | 10 | 10 | GBP███.██ |
| Hungary | producer price (ex-factory) | 2 | 3 | HUF███.██ |
| Belgium | public | 1 | 1 | EUR███.██ |
260 pack listings across 135 brand entries and 9 price bases, refreshed 08 Sep 2026. Ranges span every Diclofenac pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Diclofenac in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
8 holders have a Canadian DIN containing Diclofenac, across 14 DINs, of which 8 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| HALEON CANADA ULC | 6 | 5 | VOLTAREN EMULGEL, VOLTAREN EMULGEL ACTIVE, VOLTAREN EMULGEL BACK & MUSCLE PAIN, VOLTAREN EMULGEL EXTRA STRENGTH, VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH, +1 more | Sourceable in Canada |
| TARO PHARMACEUTICALS INC | 2 | 1 | DICLOFENAC DIETHYLAMINE GEL EXTRA STRENGTH, TARO-DICLOFENAC | Sourceable in Canada |
| ENDO OPERATIONS LTD. | 1 | 1 | PENNSAID | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 1 | 1 | JAMP DICLOFENAC TOPICAL SOLUTION | Sourceable in Canada |
| APOTEX INC | 1 | 0 | APO-DICLOFENAC | No marketed DIN |
| HIKMA CANADA LIMITED | 1 | 0 | DICLOFENAC SODIUM SOLUTION | No marketed DIN |
| PHARMASCIENCE INC | 1 | 0 | PMS-DICLOFENAC | No marketed DIN |
| STERIMAX INC | 1 | 0 | DICLOFENAC TOPICAL SOLUTION | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 2.32 % |
|---|---|
| Dosage form | GEL |
| Route | TOPICAL |
| Pack configuration (monograph) | VOLTAREN EMULGEL Extra Strength: 30 g, 60 g and 100 g tubes in cartons with a dosing card. VOLTAREN EMULGEL Joint Pain Extra Strength: 100 g tubes in cartons with a dosing card. |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Diclofenac |
|---|---|
| ATC code | M02AA15 |
| AHFS class | 28:08.04.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02465043 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2465043 |
| Brand name | VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH |
| Generic / active ingredient | DICLOFENAC DIETHYLAMINE : 2.32 % |
| Market authorization holder | HALEON CANADA ULC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | M02AA15 |
| ATC anatomical main group | M — Musculo-skeletal system |
| ATC therapeutic subgroup | M02AA |
| Current status | MARKETED |
| Status date | 25-Jun-2026 |
| Original market date | 2018-06-27 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Diclofenac in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by PHARMA STULLN INC., last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
8 of 14 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP DICLOFENAC TOPICAL SOLUTION | 1.5 % | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | 02472309 |
| PENNSAID | 1.5 % | SOLUTION | ENDO OPERATIONS LTD. | MARKETED | 02247265 |
| TARO-DICLOFENAC | 1.5 % | SOLUTION | TARO PHARMACEUTICALS INC | MARKETED | 02420988 |
| VOLTAREN EMULGEL ACTIVE | 1.16 % | GEL | HALEON CANADA ULC | MARKETED | 02554801 |
| VOLTAREN EMULGEL BACK & MUSCLE PAIN | 1.16 % | GEL | HALEON CANADA ULC | MARKETED | 02465035 |
| VOLTAREN EMULGEL EXTRA STRENGTH | 2.32 % | GEL | HALEON CANADA ULC | MARKETED | 02393190 |
| VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH | 1.16 % | GEL | HALEON CANADA ULC | MARKETED | 02338580 |
| APO-DICLOFENAC | 1.5 % | SOLUTION | APOTEX INC | APPROVED | 02354403 |
| DICLOFENAC DIETHYLAMINE GEL EXTRA STRENGTH | 2.32 % | GEL | TARO PHARMACEUTICALS INC | APPROVED | 02555263 |
| DICLOFENAC SODIUM SOLUTION | 1.5 % | SOLUTION | HIKMA CANADA LIMITED | DORMANT | 02476134 |
2 · Same class — other molecules in ATC M02AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Diclofenac | APO-DICLOFENAC · DICLOFENAC DIETHYLAMINE GEL EXTRA STRENGTH · DICLOFENAC SODIUM SOLUTION · DICLOFENAC TOPICAL SOLUTION · +10 more | 14 | 8 | Yes |
| Bufexamac | NORFEMAC CREAM - 5% · NORFEMAC OINTMENT - 5% | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC M02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| M02AC | Preparations With Salicylic Acid Derivatives | 120 | 11 |
| M02AB | Capsaicin · Capsaicin And Similar Agents · Zucapsaicin | 26 | 0 |
| M02AX | Dimethyl Sulfoxide · Various | 60 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH called?
The same molecule, Diclofenac, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| CLOFENE | Latin | Morocco |
| VOLTARENE | Latin | Morocco |
| DIFAL | Latin | Morocco |
| XENID | Latin | Morocco |
| CATAFLAM | Latin | Morocco |
| DICLOBERL | Latin | Morocco |
| Diclofenac Sandoz | Latin | Australia |
| DICLOFENAC-WGR | Latin | Australia |
| DICLOMAX | Latin | Morocco |
| Fenac EC | Latin | Australia |
| Voltaren | Latin | South Africa |
| Voltaren Emulgel | Latin | South Africa |
| FENAC PROMOPHARM | Latin | Morocco |
| Panamor Gel | Latin | South Africa |
| PHARMAFLAM | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.